GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Smolensk State Medical University (SSMU), Krupskaya Str. 28 Smolensk 214019, Russia.
J Antimicrob Chemother. 2022 Sep 6;77(Suppl_1):i61-i69. doi: 10.1093/jac/dkac218.
Antimicrobial reistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action.
To review AMR in Russia and any initiatives addressing it. Identifying any areas where more information is required will provide a call to action to minimize any further rise in AMR within Russia and to improve patient outcomes.
National AMR initiatives, antibiotic use and prescribing, and availability of susceptibility data, in particular for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines commonly used locally for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) were also reviewed, plus local antibiotic availability. Insights from both a local clinician and a local clinical microbiologist were sought to contextualize this information.
Russia launched a national strategy in 2017 to prevent the spread of AMR and the WHO reports that as of 2020-21, it is being implemented and actively monitored. Reports suggest outpatient antibiotic use of antibiotics is high and that non-prescription access and self-medication are very common. Antibiotic susceptibility studies in Russia include PeHASus, a multicentre epidemiological study focusing on susceptibilities of community-acquired respiratory pathogens and international studies such as Survey of Antibiotic Resistance (SOAR), Antimicrobial Testing Leadership and Surveillance (ATLAS) and SENTRY Antimicrobial Surveillance Program. International guidelines are used to support the development of local guidelines in Russia, and for the common CA-RTIs Russian clinicians use of several country-specific local antibiotic prescribing guidelines. A standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Russia, could make guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve patient outcomes.
抗菌药物耐药性(AMR)是对全球公共卫生的最大威胁之一。除其他因素外,耐药菌的选择是由抗生素的不当使用驱动的。由于不必要的抗生素处方,COVID-19 可能加剧了 AMR。需要了解国家层面的知识,以了解应对措施的选择。
综述俄罗斯的 AMR 情况以及应对 AMR 的各项举措。确定需要更多信息的领域,将为俄罗斯采取行动,尽量减少 AMR 的进一步上升并改善患者结局提供契机。
确定国家 AMR 举措、抗生素使用和处方以及药敏数据的可获得性,特别是针对关键的社区获得性呼吸道感染(CA-RTI)病原体肺炎链球菌和流感嗜血杆菌。还审查了当地常用于特定 CA-RTIs(社区获得性肺炎、急性中耳炎和急性细菌性鼻-鼻窦炎)的国家和国际抗生素处方指南,以及当地抗生素的可获得性。从当地临床医生和临床微生物学家那里获取了相关见解,以便了解这些信息。
俄罗斯于 2017 年启动了一项国家战略,以防止 AMR 的传播,世界卫生组织报告称,截至 2020-21 年,该战略正在实施并得到积极监测。报告显示,门诊抗生素使用量较高,非处方获取和自我用药非常普遍。俄罗斯的抗生素药敏研究包括 PeHASus,这是一项多中心流行病学研究,重点是社区获得性呼吸道病原体的药敏性,以及国际研究,如抗生素耐药性调查(SOAR)、抗生素测试领导和监测(ATLAS)和 SENTRY 抗菌监测计划。国际指南用于支持俄罗斯制定当地指南,俄罗斯的临床医生针对常见的 CA-RTIs 使用了几种具有国家特异性的当地抗生素处方指南。在制定当地指南时采用标准化的包容性方法,使用俄罗斯社区获得性感染分离株的最新监测数据,可以使指南的使用更符合当地临床医生的实际情况。这将为提高抗生素处方的适当性和提高遵从性铺平道路。这反过来又可能限制 AMR 的发展并改善患者结局。